AB 1843: Communicable diseases: hepatitis C.

The bill aims to protect individuals with hepatitis C by prohibiting health care service plans and health insurers from subjecting these individuals to prior authorization requirements for direct-acting antiviral drugs. These drugs are medically necessary for the treatment of hepatitis C. The bill also requires health care service plans and health insurers to align their clinical criteria for hepatitis C treatment with current guidelines and the standard of care. This ensures that individuals receive the best possible treatment for their condition. The bill also makes a willful violation of these provisions a crime.